Robert John Anderson, MD

Department

Medicine

Position

Professor

Books

• The Art of Neuroendocrinology : A Case-Based Approach to Medical Decision-Making
  Yousefian Shervin, Cushing’s disease identified post-adrenalectomy for adrenal nodules [Book Chapter] 2017

Publications

• BMJ Open
  Leehey David J., Pentoxifylline in diabetic kidney disease (VA PTXRx)
  11:8 2021
• Journal of the Endocrine Society
  Reddy Chandrika, Bilateral Atypical Femoral Fracture(AFF) After Teriparatide and Subsequent Anti-Resorptive Therapy: A Management Dilemma
  5:Suppl 1, p. A184 - A184 2021
• New England Journal of Medicine
  Wiviott S. D., Dapagliflozin and cardiovascular outcomes in type 2 diabetes
  380:4, p. 347 - 357 2019
• Critical care medicine
  Nayfeh ALI, 301: A CHALLENGING CASE OF HYPERTHYROIDISM IN PREGNANCY
  47:1 Suppl 1, p. 132 - 132 2019
• Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
  Drincic Andjela, Pituitary Evaluation in Patients with Low Prostate Specific Antigen (PSA): A Case-Control Study
  24:12, p. 1030 - 1037 2018
• Endocrine Practice
  Drincic Andjela, Pituitary evaluation in patients with low prostate-specific antigen
  24:12, p. 1030 - 1037 2018
• Endocrine Practice
  Singh Shilpi, AN UNUSUAL CASE OF CONCOMITANT HYPERALDOSTERONISM AND HYPERCORTISOLISM IN A PATIENT WITH ADRENAL INCIDENTALOMA
  23, p. 6 - 7 2017
• JAMA Internal Medicine
  Puttnam Rachel, Association of 3 different antihypertensive medications with hip and pelvic fracture risk in older adults secondary analysis of a randomized clinical trial
  177:1, p. 67 - 76 2017
• AACE Clinical Case Reports
  Joven Mark Henry, Pneumocystis jirovecii Pneumonia Associated with Systemic Glucocorticoids in the Treatment of Type 2 Amiodarone-Induced Thyrotoxicosis
  2:1, p. e46 - e49 2016
• Endocrine Practice
  Nguyen Anh-Thu, Refractory Hypothyroidism Due to L-Thyroxine Malabsorption
  22, p. 301 - 302 2016
• AACE Clinical Case Reports
  Joven Mark Henry, Follicular Thyroid Cancer with Pulmonary Metastasis Presenting as Toxic Autonomously Functioning Thyroid Nodule
  1:1, p. e49 - e52 2015
• Endocrine Pathology
  Shah K., Case of Concurrent MTC and PTC in a Patient with a Germline RET Mutation
  26:3, p. 279 - 283 2015
• Endocrine
  Joven Mark Henry, Marine-lenhart syndrome
  49:2, p. 570 - 571 2015
• Current Diabetes Reports
  Joven Mark Henry, Update on blood pressure control and renal outcomes in diabetes mellitus
  15:44, p. (13 pages) 2015
• Tarasova Valentina D., Letters to the editor 2014
• BMJ case reports
  Shah Kinjal K., Acute secondary adrenal insufficiency as the presenting manifestation of small-cell lung carcinoma
  2014 2014
• Frontiers in Endocrinology
  Zimering Mark B., Endothelial cell autoantibodies in predicting declining renal function, end-stage renal disease, or death in adult type 2 diabetic nephropathy
  5:AUG 2014
• Diabetes, Obesity and Metabolism
  Rissanen Aila, Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes
  14:12, p. 1088 - 1096 2012
• Metabolism: Clinical and Experimental
  Zimering Mark B., Increased plasma basic fibroblast growth factor is associated with coronary heart disease in adult type 2 diabetes mellitus
  60:2, p. 284 - 291 2011
• Metabolism: Clinical and Experimental
  Zimering Mark B., Endothelial cell inhibitory autoantibodies are associated with laser photocoagulation in adults from the Veterans Affairs Diabetes Trial
  58:6, p. 882 - 887 2009
• Atherosclerosis
  Saremi Aramesh, Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT)
  203:2, p. 610 - 614 2009
• Metabolism: Clinical and Experimental
  Zimering Mark B., Low plasma basic fibroblast growth factor is associated with laser photocoagulation treatment in adult type 2 diabetes mellitus from the Veterans Affairs Diabetes Trial
  58:3, p. 393 - 400 2009
• Metabolism: Clinical and Experimental
  Zimering Mark B., Plasma basic fibroblast growth factor is correlated with plasminogen activator inhibitor-1 concentration in adults from the Veterans Affairs Diabetes Trial
  57:11, p. 1563 - 1569 2008
• Endocrine Practice
  Drincic Andjela, Association of low prostate-specific antigen concentration and panhypopituitarism
  14:4, p. 432 - 436 2008
• Endocrinology
  Pietsch C. A., Thyronamines are substrates for human liver sulfotransferases
  148:4, p. 1921 - 1927 2007
• Steroids
  Wang Min, Sulfation of tibolone metabolites by human postmenopausal liver and small intestinal sulfotransferases (SULTs)
  71:5, p. 343 - 351 2006
• Journal of Clinical Endocrinology and Metabolism
  Ebmeier Christopher C., Human thyroid phenol sulfotransferase enzymes 1A1 and 1A3: Activities in normal and diseased thyroid glands, and inhibition by thyroid hormones and phytoestrogens
  89:11, p. 5597 - 5605 2004
• Biological Trace Element Research
  Wells Ibert C., Abnormal magnesium metabolism in etiology of salt-sensitive hypertension and type 2 diabetes mellitus
  98:2, p. 97 - 108 2004
• Biochemical and Biophysical Research Communications
  Wells Ibert C., A test for adequacy of chromium nutrition in humans - Relation to Type 2 diabetes mellitus
  303:3, p. 825 - 827 2003
• Endocrine Practice
  Hodgson Stephen F., American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis
  9:6, p. 544 - 564 2003
• Bone
  Dubin R. L., Thermostable (SULT1A1) and thermolabile (SULT1A3) phenol sulfotransferases in human osteosarcoma and osteoblast cells
  28:6, p. 617 - 624 2001
• Endocrine Practice
  Cobin R. H., AACE/AAES medical/surgical guidelines for clinical practice
  7:3, p. 202 - 220 2001
• Journal of Endocrinology
  Li X., Characterization of human liver thermostable phenol sulfotransferase (SULT1A1) allozymes with 3,3′,5-triiodothyronine as the substrate
  171:3, p. 525 - 532 2001
• Biochemical Pharmacology
  Li Xinying, Sulfation of iodothyronines by human sulfotransferase 1C1 (SULT1C1)
  60:11, p. 1713 - 1716 2000
• Diabetes Research and Clinical Practice
  Piper Beth, Incidence of reported gastrointestinal and hypoglycemic symptoms with metformin/glyburide tablets as first-line therapy in type 2 diabetes
  50, Supplement 1, p. 49 2000
• Biochemical and Biophysical Research Communications
  Li Xinying, Sulfation of iodothyronines by recombinant human liver steroid sulfotransferases
  263:3, p. 632 - 639 1999
• JAMA - Journal of the American Medical Association
  Preston Richard A., Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy
  280:13, p. 1168 - 1172 1998
• Chemico-Biological Interactions
  Anderson Robert J., Sulfation of minoxidil by multiple human cytosolic sulfotransferases
  109:1-3, p. 53 - 67 1998
• Biochemical Pharmacology
  Kudlacek Patrick E., Characterization of recombinant human liver dehydroepiandrosterone sulfotransferase with minoxidil as the substrate
  53:2, p. 215 - 221 1997
• FASEB Journal
  Kudlacek P., Characterization of recombinant human liver dehydroepiandrosterone sulfotransferase (DHEA ST) with minoxidil as the substrate
  10:3, p. A456 1996
• The Nebraska medical journal
  Adickes E. D., Sternomastoid rhabdomyoma mimicking a thyroid nodule.
  81:11, p. 359 - 362 1996
• Biochemical and Biophysical Research Communications
  Kudlacek Patrick E., Characterization of recombinant human liver thermolabile phenol sulfotransferase with minoxidil as the substrate
  210:2, p. 363 - 369 1995
• Thyroid
  Anderson R. J., Human liver triiodothyronine sulfotransferase
  5:1, p. 61 - 66 1995
• Journal of Pharmacology and Experimental Therapeutics
  Kudlacek P. E., Human skin and platelet minoxidil sulfotransferase activities
  273:2, p. 582 - 590 1995
• Current Opinion in Oncology
  Anderson R. J., Familial risk for neuroendocrine tumors
  5:1, p. 75 - 84 1993
• Gut
  Robert A., Morphological and functional gastric cytoprotection by prostaglandin in rats receiving absolute ethanol orally
  33:4, p. 444 - 451 1992
• The Journal of Laboratory and Clinical Medicine
  Anderson Robert J., Localization of human blood phenol sulfotransferase activities
  118:5, p. 500 - 509 1991
• Clinica Chimica Acta
  Anderson Robert J., Human platelet thermostable phenol sulfotransferase
  189:2, p. 221 - 229 1990
• The Journal of Laboratory and Clinical Medicine
  Anderson Robert J., Human platelet thermostable phenol sulfotransferase from blacks and whites
  112:6, p. 773 - 783 1988
• Clinica Chimica Acta
  Sinsheimer Erica G., Human pheochromocytoma phenol sulfotransferase
  164:1, p. 55 - 70 1987
• Neuroendocrinology
  Anderson R. J., Human pituitary phenol sulfotransferase
  44:1, p. 117 - 124 1986
• Clinica Chimica Acta
  Anderson Robert J., Human platelet phenol sulfotransferase
  138:2, p. 185 - 196 1984
• Synthesis (Germany)
  Arora S. K., A convenient single step preparation of dopamine-4-o-sulfate
  1984:10, p. 884 - 885 1984
• Gastroenterology
  Robert André, Lack of Correlation Between Mucus Gel Thickness and Gastric Cytoprotection in Rats
  86:4, p. 670 - 674 1984
• Journal of Neurochemistry
  Butler Paula R., Human Platelet Phenol Sulfotransferase
  41:3, p. 630 - 639 1983
• Biochemical Pharmacology
  Maus Timothy P., Rat phenol sulfotransferase. Assay procedure, developmental changes, and glucocorticoid regulation
  31:5, p. 849 - 856 1982
• Clinical Endocrinology
  ANDERSON R. J., ACROMEGALY AND PITUITARY ADENOMA WITH PHAEOCHROMOCYTOMA
  14:6, p. 605 - 612 1981
• Clinica Chimica Acta
  Anderson Robert J., Human platelet phenol sulphotransferase
  110:2-3, p. 157 - 167 1981
• Clinica Chimica Acta
  Anderson R. J., Phenolsulphotransferase in human tissue
  103:1, p. 79 - 90 1980
• Pharmacologist
  Maus T. P., Effect of dexamethasone on rat phenolsulphotransferase (PST) activity
  22:3, p. No. 773 1980
• Journal of Laboratory and Clinical Medicine
  Anderson R. J., Phenolsulphotransferase
  94:1, p. 158 - 171 1979
• Pharmacologist
  Anderson R. J., Phenolsulphotransferase (PST)
  20:3, p. No. 371 1978
• Clinical Nuclear Medicine
  Anderson R. J., Thyroid scintigram in familial medullary carcinoma of the thyroid gland
  3:4, p. 147 - 151 1978

Presentations

• Jinnur, S.P., Anderson, R.J.: Synchronous Occurrence of Ipsilateral Adrenocortical Carcinoma and Renal Cell carcinoma: A rare case report. Accepted for e-poster presentation. AACE Annual Meeting 2023 Seattle, WA, May 4-6, 2023. 2023
• TBL Proctor, M2 Introduction to Clinical Medicine "Cushings" (2 hours) October 13, 2022. 2022
• Speaker, M2 Introduction to Clinical Medicine (1 hour), "Adrenal," CUSM, October 11, 2022. 2022
• TBL Proctor, M2 Introduction to Clinical Medicine Thyroid (2 hours) October 7, 2022. 2022
• CBL Proctor, M2 Introduction to Clinical Medicine Pituitary (1 hour) October 6, 2022. 2022
• Speaker, M2 Introduction to Clinical Medicine (1 hour), "Thyroid," CUSM, October 5, 2022. 2022
• Speaker, "Thyroid Ultrasound and FNA Applications." Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE , August 16, 2022. 2022
• Speaker, M2 Introduction to Clinical Medicine (1 hour), "Hypothalamic-Pituitary Function and Disease," CUSM, October 3, 2022. 2022
• Demonstrator, "Thyroid Biopsy Simulation Workshop (2 hours)." Endocrine Fellowship Core Series, VAMC, Section of Endocrinology, Omaha, NE, July 8, 2022. 2022
• Speaker, "Pituitary" Physician Assistant Endocrine Course, CUSM, 1 hour, June 13, 2022. 2022
• Speaker, "Adrenal" Physician Assistant Endocrine Course, CUSM, 1 hour, June 13, 2022. 2022
• Jinnur, S.P., Anderson, R.J., Bauer, A.M., Akbik, O.S.: Giant Growth Hormone (GH)-Secreting Pituitary Tumor with Massive Sphenoid Sinus Invasion and Spontaneous Cerebrospinal Fluid (CSF) Leak: A Case Report. Presented ENDO2022. In Press: Journal of the Endocrine Society, Volume 6, Issue Supplement June 2022. 2022
• Speaker, "Cushings Disease: Diagnosis and Management Update" Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, March 29, 2022. 2022
• Speaker, "Pituitary Disease Diagnosis and Treatment:Update" Endocrine Fellowship Core Lectures, Department of Medicine, Division of Endocrinology, Omaha, NE, February 22, 2022. 2022
• Thyroid Nodules and Ultrasound. Anderson, R. Creighton University Endocrinology Grand Rounds, Omaha, NE. 2019
• Inpatient Management of DM. Anderson, R., George, A. Creighton University Department of Medicnie Grand Rounds, Omaha, NE. 2019
• Hyperthyroidism: Uncommon Presentations and Treatments Challenges. Anderson, R. Creighton University Endocrinology Grand Rounds, Omaha, NE. 2019
• Autoimmune thyroid disease: Hypothyroidism conversion to Hyperthyroidism. Kunwar, S., Nagireddi, R., Anderson, R., Zena, M. AACE 2019, Los Angeles, CA. 2019
• Octreotide Long-Acting Release (OCT-LAR) Use in Pregnancy: Is It Considered Safe? Lin, W., Anderson, R. AACE 2019, Los Angeles, CA. 2019
• Congenital Adrenal Hyperplasia with Testicular Adrenal Rest Tumors and Bilateral Adrenal Myelolipomas: A Treatment Dilemma. Nagireddi, R., Anderson, R. AACE 2019, Los Angeles, CA. 2019
• Growth Hormone Deficiency (GHD) over 4 years after mild traumatic Brain Injury in deployed veterans. Lin, W., Anderson, R. Endocrine Society 2019, New Orleans, LA. 2019
• Faculty Speaker, "Traumatic Brain Injury and Endocrine Dysfunction in Veterans," Creighton Department of Medicine Grand Rounds, Omaha, NE, December 16, 2015. 2015
• Speaker, "Thyroid Nodules" Medicine Resident Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, October 23, 2015 2015
• Speaker, "Thyroid Update" Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, July 7, 2015 2015
• Speaker, "Mild Traumatic Brain Injury and Pituitary Dysfunction: Update," Creighton Department of Medicine Research Conference, Omaha, NE, May 14, 2015 2015
• Speaker, "Pheochromocytoma," Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, May 12, 2015. 2015
• Speaker, Pituitary Board Reviews, Internal Medicine Board Review Lectures, CUMC, May 11, 2015. 2015
• Faculty Moderator "Adrenal 2," Department of Medicine Reisdent Core Lectures, April 6, 2015. 2015
• Faculty Moderator "Adrenal 1," Department of Medicine Resident Core Lectures, March 30, 2015. 2015
• Faculty Moderator "Thyroid," Department of Medicine Reisdent Core Lectures, March 23, 2015. 2015
• M2 Introduction to Clinical Medicine (1 hour), "Adrenal," CUSM, January 27, 2015. 2015
• M2 Introduction to Clinical Medicine (1 hour), "Hypothalamic-Pituitary Function and Disease," CUSM, January 26, 2015. 2015
• Speaker, "Cushings Update" Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, January 20, 2015. 2015
• Board Reviews; Endocrine Fellows, November 25, 2014. 2014
• Speaker, "Mild Traumatic Brain Injury and Pituitary Dysfunction," Creighton Department of Medicine Research Conference, Omaha, NE, October 9, 2014. 2014
• Speaker, "Cushings" Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, September 16, 2014. 2014
• Speaker, "Thyroid Physiology" Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, July 22, 2014,. 2014
• Invited speaker, "Endocrine Emergencies," Acute Care Core Curriculum Series, Department of Medicine, Omaha, NE, July 2, 2014. 2014
• Speaker, "Genetic screening and counseling in endocrine metabolic diseases," Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, July 1, 2014. 2014
• Speaker, Thyroid Board Reviews, Internal Medicine Board Review Lectures, CUMC, June 2, 2014. 2014
• Speaker, "Acromegaly" Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, May 27, 2014. 2014
• Speaker, "Pheochromocytoma," Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, February 18, 2014. 2014
• Invited Speaker, DKA and HHS Treatment Approaches with Insulin Infusion," Pulmonary and Critical Medicine Conference, CUMC, Omaha, NE, February 7, 2014. 2014
• M2 Introduction to Clinical Medicine (1 hour), "Adrenal," CUSM, January 28, 2014. 2014
• M2 Introduction to Clinical Medicine (1 hour), "Hypothalamic-Pituitary Function and Disease," CUSM, January 27, 2014. 2014
• Speaker, "VA-NEPHRON-D: End of combination therapy for diabetic Nephropathy?" Department of Medicine Grand Rounds, CUMC, December 18, 2013. 2013
• Speaker, "Thyroid Ultrasound and FNA Applications." Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, December 17, 2013. 2013
• Invited Speaker, "Veterans Affairs Diabetes Trial (VADT) and Renal Outcomes," Research Conference, Department of Medicine, Omaha, NE, November 14, 2013. 2013
• Speaker, "Diabetic Emergencies: DKA and HHS," Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, November 12, 2013. 2013
• Speaker, "Mild Traumatic Brain Injury and Pituitary Dysfunction," Creighton Osteoporosis Research Center Friday Conference, Omaha, NE, November 8, 2013. 2013
• Speaker, "Cushings" Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, September 24, 2013. 2013
• Invited speaker, "Endocrine Emergencies," Acute Care Core Curriculum Series, Department of Medicine, Omaha, NE, August 8, 2013. 2013
• Speaker, "Hypothyroidism Update," Endocrine Fellowship Core Series, Department of Medicine, Division of Endocrinology, Omaha, NE, July 30, 2013 2013
• Guest Speaker, Metabolism of tibolone metabolites in human tissues, Advisory Meeting, San Diego, CA 2005
• Invited speaker, "Internal Medicine Board Reviews-Endocrinology (1.5 hours)," 2005
• Invited Speaker, "Antithyroid Drugs," Morning Report, Department of Medicine, VAMC 2005
• Guest Speaker (Funded), "Sulfation of Tibolone Metabolites by Human Postmenopausal Tissues," Tibolone Metabolism Symposium, Philadelphia, PA, March 31, 2005. 2005
• Invited Speaker, "Hypogonadism," Morning Report, Department of Medicine, VAMC 2005
• Invited Speaker, "Thyroid Nodules," Morning Report, Department of Medicine, VAMC 2005
• Invited Speaker, "Initiation of Insulin in Diabetes Mellitus," Morning Report, Department of Medicine, VAMC 2004
• Invited Speaker, "Subclinical Thyroid Disease," Morning Report, Department of Medicine, VAMC 2004
• Invited speaker, "Endocrine Emergencies," Acute Care Core Curriculum Series, Department of Medicine, Omaha, NE, 2004
• Invited Speaker (Funded), "Metabolic Syndrome," Council Bluffs, IA, June 17, 2004. 2004
• Oral Presentation-Ebmeier, C. and Anderson, R.J.: Phytoestrogen sulfation by human thyroid phenol sulfotransferases (SULTs): Inhibition of the SULT activities by daidzein and genistein. EB(Experimental Biology)2004 International Meeting, Washington, DC 2004
• Wang, M. and Anderson, R.J.: Sulfation of tibolone metabolites by postmenopausal human liver sulfotransferase activities. EB (Experimental Biology) Poster Presentation 2004
• "Maintaining HbA1c Separation in the Long-term VADT Study." VA Diabetes Trial (VADT) COOP Study #465 Investigators Meeting, Chicago, IL 2004
• Invited speaker, "Nazi Doctors" Grand Rounds, Omaha, NE, March 24, 2004. 2004
• Invited speaker, Treatment of Thyroid Diseases, Family Practice Lecture Series, Omaha, NE 2004
• Invited Speaker, "Treatment Strategies in the VA Diabetes Trial," VA Staff Physician Conference, Lincoln VAMC, Lincoln, NE 2003
• Invited Speaker (Funded), "Diabetic Dyslipidemia: Treatment Update," Marshalltown Iowa Medical Staff Meeting 2003
• Invited speaker, "Endocrine Emergencies," Acute Care Core Curriculum Series, Department of Medicine, Omaha, NE 2003
• Guest Symposium Speaker, "Blood pressure control in the VA Diabetes Trial (VADT)," Clinical Trials Symposium, Endocrine Society 2003, Philadelphia, PA 2003
• Blood pressure control in the Veterans Affairs Diabetes Trial (VADT) 2003
• Thyroid Hormone Metabolism:reSULTs and inSULTs. Creighton University Department of Medicine Research Conference 2003
• Speaker, "Hormones for Aging Men: HRT Deja Vu?" Creighton University School of Medicine Grand Rounds 2003
• Invited Speaker, "Choosing Appropriate Patients for Weight Loss," Morning Report, Department of Medicine, VAMC. 2003
• Research in Type 2 Diabetes at the VA 2003
• Invited Speaker, "Hyperglycemia in Acutely Ill Patients," Morning Report, Department of Medicine, VAMC. 2002
• Invited Speaker, "Subclinical Thyroid Disease," Morning Report, Department of Medicine, VAMC. 2002
• Invited Speaker amd Moderator (Funded), "Diabetes Treatment Programs:CADRE," Ironwood Golf Club, Omaha Nebraska, November 2, 2002. 2002
• Invited Speaker (Funded), "Managing Methods and Strategies for ATP III Goal Attainment: Conquering the New Treatment Frontier," Nick and Tonys, Omaha, Nebraska. 2002
• Invited Speaker, "Drugs for treatment of Diabetes- An Update," Nursing Inservice, Ambulatory Care, VAMC, October 18, 2002. 2002
• Invited Speaker, "HDL Cholesterol as a risk factor," Morning Report, Department of Medicine, VAMC, October 10, 2002. 2002
• Invited speaker, "Hospital Control of Diabetes Mellitus- discussant panel," Creighton University Department of Medicine Grand Rounds, Omaha, NE. 2002
• Invited Speaker, "Prevention of Diabetes Mellitus," Morning Report, Department of Medicine, VAMC. 2002
• Invited Speaker, "Classification of Diabetes Mellitus," Morning Report, Department of Medicine, VAMC. 2002
• Invited Speaker (Funded), "Metabolic Syndrome: A Tale of the Tape-Treatment Options," The French Caf, Omaha Nebraska 2002
• Department of Medicine, "Endocrine Board Review Session" 2 hours 2002
• "Recent Classification of Diabetes Mellitus," Morning Report, Department of Medicine, VAMC 2002
• "Diabetic Nephropathy," Morning Report, Department of Medicine, VAMC 2002
• Department of Medicine Grand Rounds, "Some Endocrine Nutraceuticals: What are we to do?" 2002
• "Hospital-Based Diabetes Treatment," Morning Report, Department of Medicine, VAMC 2002
• "Hypertension in Diabetes," Morning Report, Department of Medicine, VAMC 2002
• Invited speaker, "Pituitary Apoplexy," Department of Medicine Morning Report, Omaha, NE. 2002
• Invited Speaker, "Nodular Thyroid Disease," Morning Report, Department of Medicine, VAMC. 2002
• Invited Speaker (Funded), "Optimizing Lipid Lowering: Utilizing the Most Recent Therapies in Getting Patients to Goal," The French Caf, Omaha Nebraska. 2002
• Invited Speaker, "Metabolic Syndrome," Morning Report, Department of Medicine, VAMC. 2002
• Invited Speaker, "Adrenal insufficiency," Morning Report, Department of Medicine, VAMC. 2001
• Hardin, K.N., Kudlacek, P.E., Li, X-Y, Anderson, R.J.: Thermostable phenol sulfotransferase (SULT1A1) is present in SV40 transformed African green monkey kidney cells (COS-1). Proceedings of the Southwestern and Rocky Mountain Division AAAS-SWARM, 3rd Annual Midwest Meeting (Omaha, NE, Nov. 11-13) 41 (#2):18, 2001. 2001
• Invited Speaker, "Drugs that cause hyperglycemia," Morning Report, Department of Medicine, VAMC. 2001
• Invited Speaker, "Diagnosis of Diabetes," Morning Report, Department of Medicine, VAMC. 2001
• Sype, J.W. and Anderson, R.J. : A case of long-standing hyponatremia and hypothyroidism associated with an incidentally discovered pituitary macroadenoma, ACP-ASIM, Nebraska Chapter Meeting Proceedings, 2001
• Invited Speaker, "Hyperthyroidism," Morning Report, Department of Medicine, VAMC. 2001
• Invited Speaker, "Cholesterol Guideline Update," Morning Report, Department of Medicine, VAMC. 2001
• Invited speaker, "Endocrine Emergencies," Department of Medicine, Omaha, NE, 2001
• Invited speaker, "Thyrotoxicosis," Department of Medicine Morning Report, Omaha, NE. 2001
• "ADA Recognized Diabetes Outpatient Program", VAMC, Omaha, NE 2001
• "VISN 14 Diabetes Guidelines", VAMC, Omaha, NE 2000
• "Hypopituitarism" University of Santo Tomas School of Medicine and Surgery, Manila, Philippines 2000
• Anderson RJ, Li X-Y, Clemens D: Sulfation of thyroid hormones by multiple human recrombinant cytosolic sulfotransferases (SULTs). Presentation at the International Congress of Endocrinology, Sydney, Australia 2000
• "VISN 14 Diabetes Guidelines", VAMC, Omaha, NE 2000
• "Thyroid Disease in Primary Care, Family Practice Lecture Series, Omaha, NE 2000
• "Oral agent therapy in Type 2 diabetes", VAMC Nurse Inservice, Omaha, NE 2000
• Kudlacek, P., Clemens, D., Anderson, R.: Human liver recombinant thermostable phenol sulfotransferase (SULT1A1) allozymes characterized with minoxidil. FASEB J. 13(#5):A1013, 1999 1999
• Li, X.-Y. and Anderson, R.: Sulfation of triiodothyronine by recombinant human liver steroid sulfotransferases. FASEB J. 13(#5):A813, 1999. 1999
• Kudlacek, P., Anderson, R.: Altered biochemical properties of recombinant human liver chimeric sulfotransferases (SULT). Proceedings of the Southwestern and Rocky Mountain Division AAAS, 1st Midwest Regional Meeting (Omaha, NE, October 31- November 2) 39 (#2):24, 1999 1999
• Li, X.-Y., Clemens, D., Anderson, R.: Thyroid hormone sulfation by recombinant human sulfotransferase SULT1C1. Proceedings of the Southwestern and Rocky Mountain Division AAAS, 1st Midwest Regional Meeting (Omaha, NE, October 31- November 2) 39 (#2):25, 1999. 1999
• Department of Medicine Grand Rounds, "Adult Male Hypogonadism," August 18, 1999. 1999
• Invited (Funded) Commentator, "Side Effects and adverse events with adult growth hormone therapy," 3rd Annual International HypoCCS Meeting, Lido at Venice, Italy, April 17, 1999 1999
• Invited (Funded) Speaker, Robert Bolinger Annual Lecture, "Androgen replacement therapy for adult male hypogonadism: ART for ADAM," UKMC Departments of Medicine and Endocrinology, Kansas City, Kansas, April 7, 1999 1999
• Invited (Funded) Guest Lectureship, "Male Hypogonadism Case Discussions," Medical Education Dinner, UKMC Department of Endocrinology, Kansas City, MO, April 6, 1999 1999
• Invited (Funded) Guest Lectureship, "Androgen deficiency in the adult male: Diagnosis and Treatment," Medical Education Conference, Good Samaritan Hospital/ Health Systems, Kearney, NE, March 12, 1999. 1999
• Invited Lecturer, "MEN Syndromes", UNMC Endocrinology Conference, UNMC and VA Medical Centers, Omaha, NE, January 12, 1999. 1999
• Invited (Funded) Guest Lectureship, "When and how to treat the androgen deficient adult male", Department of Medicine Grand Rounds, Rose Medical Center, University of Colorado Health Sciences Center, Denver, CO, January 5, 1999. 1999

Awards

• Alpha Omega Alpha Honorary
  2017 Alpha Omega Alpha Honorary elected as Faculty.
• Performance Award- Special Contribution to the Department of Veterans Affairs Mission
• Visiting Professor of Endocrinology to University of Santo Tomas School of Medicine and Surgery, Manila, Philippines
• VA Merit Review Award;